BACKGROUND Metabolomic profiling in individuals with chronic kidney disease (CKD) has the potential to identify novel biomarkers and provide insight into disease pathogenesis. METHODS We examined the association between blood metabolites and CKD progression. defined as the subsequent development of end-stage renal disease (ESRD) or estimated glomerular filtrate rate (eGFR) halving. in 1. https://herbsdailyes.shop/product-category/capsules-gels/